October 01, 2021 Press release

EMA implements new measures to minimise animal testing during medicines development


EMA is putting in place special support to developers to replace, reduce and refine animal use for the development, manufacturing and testing of human and veterinary medicines. The Agency is promoting these three principles — replace, reduce and refine; commonly referred to as 3Rs — through EMA’s Innovation Task Force (ITF). This action will facilitate the development and implementation of New Approach Methodologies (NAMs) that are in line with the European Union legislation on the protection of animals used for scientific purposes.

More information see the EMA website.

Source: https://www.ema.europa.eu/en/news/ema-implements-new-measures-minimise-animal-testing-during-medicines-development


Sharing knowledge: the latest news

Subscribe to our Newsletter

Would you like to stay updated about Organ-on-Chip topics? Subscribe to our newsletter and receive monthly updates about EURooCS and Organ-on-Chip.